Hmgstat R 40 Tablet contains Rosuvastatin 40 mg, a potent lipid-lowering agent belonging to the statin class. It is primarily indicated for the treatment of hypercholesterolemia and mixed dyslipidemia to reduce elevated total cholesterol, low-density lipoprotein cholesterol (LDL-C), apolipoprotein B, and triglycerides, while increasing high-density lipoprotein cholesterol (HDL-C). Rosuvastatin acts by selectively inhibiting HMG-CoA reductase, the rate-limiting enzyme in cholesterol biosynthesis, leading to decreased cholesterol production and increased clearance of LDL particles from the bloodstream. This mechanism contributes to the reduction of atherosclerotic plaque formation and decreases the risk of cardiovascular events such as myocardial infarction, stroke, and angina in patients with or at risk for cardiovascular disease. Hmgstat R 40 is indicated as adjunctive therapy to diet and lifestyle modifications in adults with primary hyperlipidemia, familial hypercholesterolemia, and mixed dyslipidemia. It should be used with caution in patients with hepatic impairment and monitored for potential adverse effects including myopathy and elevated liver enzymes. Regular lipid profile assessments and liver function tests are recommended during therapy. Contraindications include active liver disease and pregnancy. Patient adherence to prescribed dosage and medical supervision is essential for optimal therapeutic outcomes.